본문 바로가기
KERD
논문KCI 등재

돼지 마이코플라즈마 폐렴 예방백신의 접종시기별 방어효과에 관한 연구

Evaluation of vaccination against Mycoplasma hyopneumoniae in pigs at different vaccination time-points

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류수의학

초록

This study was performed to evaluate the effect of commercial swine mycoplasma vaccine(M+Pac®,Schering-Plough Animal HealthCo.) at different vaccination time-points. Total 139 piglets were moved to experimental farm after weaning and were randomly allocated to 3 treatment groups and 1 control group. Piglets of 3 treatment groups(A, B and C) were vaccinated twice at 1 and 3 weeks(A group), 3 and 5 weeks (B), and 6 and 8 weeks(C), respectively. All vaccinates showed higher antibody titers compared with nonvaccinates, and maintained to finish(P<0.001). Performance and RBC/WBC count showed no significant difference between groups. Vaccinates at 6-8 weeks showed better effect on decrease of clinical sign compared with vaccinates at 1-3 weeks and 3-5 weeks and nonvaccinates. Also, lung lesion assessment showed significant difference between vaccinates at 3-5 weeks and 6-8 weeks, and nonvaccinates and vaccinates at 1-3 weeks(P<0.05). Vaccinates at 3-5 weeks showed 63.6% of reduction rate in lung lesion score, which is the lowest lung lesion score in comparison with other groups. In conclusion, these results suggested that vacci-nation at 3-5 weeks or later may be more effective than earlier vaccination.

Abstract

This study was performed to evaluate the effect of commercial swine mycoplasma vaccine(M+Pac®,Schering-Plough Animal HealthCo.) at different vaccination time-points. Total 139 piglets were moved to experimental farm after weaning and were randomly allocated to 3 treatment groups and 1 control group. Piglets of 3 treatment groups(A, B and C) were vaccinated twice at 1 and 3 weeks(A group), 3 and 5 weeks (B), and 6 and 8 weeks(C), respectively. All vaccinates showed higher antibody titers compared with nonvaccinates, and maintained to finish(P<0.001). Performance and RBC/WBC count showed no significant difference between groups. Vaccinates at 6-8 weeks showed better effect on decrease of clinical sign compared with vaccinates at 1-3 weeks and 3-5 weeks and nonvaccinates. Also, lung lesion assessment showed significant difference between vaccinates at 3-5 weeks and 6-8 weeks, and nonvaccinates and vaccinates at 1-3 weeks(P<0.05). Vaccinates at 3-5 weeks showed 63.6% of reduction rate in lung lesion score, which is the lowest lung lesion score in comparison with other groups. In conclusion, these results suggested that vacci-nation at 3-5 weeks or later may be more effective than earlier vaccination.

참고문헌 (33)

  1. Whittlestone P, "Porcine mycoplasmas", pp.133~176 (1979), Academic Press New York
  2. Switzer WP, "Myco-plasma diseases. In: Diseases of Swine", pp.741~764 (1975), Iowa State University
  3. Baskerville A, "Pneumonia of pigs", N Z Vet J, 29, pp.216~218 (1981)
  4. Messier S, "Interaction of Mycoplasma hyopneumoniae membranes with porcine lymphocytes", Am J Vet Res, 52, pp.1497~1502 (1991)
  5. Gois M, "Microbio-logical findings in the lungs of slaughter pigs", Proc Int Pig Vet Soc, 6, pp.213~ (1988)
  6. Young T, "Preva-lence of antibodies to Mycoplasma hyo-pneumoniae in Iowa swine", Am J Vet Res, 44, pp.1946~1948 (1983)
  7. Farrington DO, "Immunization of swine against mycoplasmal pneumonia", Proc Int Pig Vet Soc, 4, pp.4~ (1976)
  8. Clark LK, "Investigating thetransmission of Mycoplasma hyopneumoniae in swine herd with enzootic pneumonia", pp.543~550 (1991), Vet Med
  9. Goodwin RFW, "Apparent re-infec-tion of enzootic pneumonia-free pig herbs: Search for possible causes", Vet Rec, 116, pp.690~694 (1985)
  10. Pointon AM, "Effect of enzootic pneumonia of pigs on growth performance", Aust Vet J, 62, pp.13~18 (1985)
  11. Scheidt AB, "Relationship of growth perfor-mance to pneumonia and atrophic rhinitis detected in pig satslaughter", JAVMA, 196, pp.881~884 (1990)
  12. Noyes EP, "Comparison of the effect of pneumonia detected during lifetime with pneumonia detected at slaughter on growth in swine", JAVMA, 197, pp.1025~1029 (1990)
  13. Thomsen BL, "The Cox regression model applied to risk factor analysis of infec-tions in the breeding and multiplying herds in the Danish SPF system", Prev Vet Med, 12, pp.287~297 (1992)
  14. Livingston CW, "Pathogenesis of mycoplas-mal pneumonia in swine", Am J Vet Res, 33, pp.2249~2258 (1972)
  15. Dayalu KI, "Evaluation of experimental vaccines for control of porcine pneumonia induced by Mycoplasma hyopneumoniae", Proc Int Congr Pig Vet Soc, 11, pp.83~ (1990)
  16. 이승욱, "통계학의 이해 2판", pp.418~422 (1998), 自由아카데미
  17. "SPSS(Statistical package for the social science) version 8.0", SPSS Inc, ~
  18. Freeman MJ, "Evaluation of the indirect hemagglutination assay as a practical serodiagnostic test for mycoplasmal pneumonia of swine", Vet Microbiol, 9, pp.259~270 (1984)
  19. Lloyd LC, "Assessment of a complement fixation test to detect Mycoplasma hyo-pneumoniae infection in pigs", Aust Vet J, 61, pp.216~218 (1984)
  20. Armstrong CH, "Comparision of the enzyme-linked immunosorbent assay and the indirect hemagglutination and complement fixation tests for detecting antibodies to Mycoplasma hyopneumoniae", Can J Comp Med, 47, pp.464~470 (1983)
  21. Bruggmann S, "Quantitative detection of antibodies to Mycoplasma suipneu-moniae in pigs’ sera by an enzyme-linked immunosorbent assay", Vet Rec, 101, pp.109~111 (1977)
  22. Nicolet J, "Tween 20 soluble proteins of Myco-plasma hyopneumoniae as antigen for an enzyme-linked immunosorbent assay", Rec Vet Sci, 29, pp.305~309 (1980)
  23. Morrow WEM, "Effect of a mycoplasma vaccine on average daily gain in swine", Swine Health and Production, 2, pp.13~18 (1994)
  24. Thacker EL, "Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins", Swine Health and Production, 6, pp.107~112 (1998)
  25. Thacker BJ, "The influence of maternally-derived anitibodies on Mycoplasma. hyopneumo-niae infection", pp.454~ (2000), The 16th Int Pig Vet Soc Cong
  26. Jayappa H, "Evaluation of the efficacy of Mycoplasma hyopneumoniae bacterin following immunization of young pigs in the presence of varying levels of maternal antibodies", pp.237~241 (2001), AASV
  27. Thacker BJ, "Influence of maternally-derived antibodies on the efficacy of a Mycoplasma hyopneumoniae bacterin", pp.513~515 (2001), AASV
  28. Osborne AD, "An abattoir survey of the incidence of pneumonia in Saskatchewan swine and an investigation of the microbiology of affected lung", Can Vet, 22, pp.82~85 (1981)
  29. Pointon AM, "An abattoir survey of the prevalence of lesions of enzootic pneumonia of pigs in south Australia", Aust Vet J, 58, pp.16~17 (1984)
  30. 박응복, "도축장에서의 폐충성 폐렴과 마이코플라즈마 폐렴의 병리조직학적 비교", 서울대학교 수의대 논문집, 2, pp.43~54 (1977)
  31. 조광현, "영남지방 도축돈의 Mycoplasma 폐렴조사 및 분리균에 대한 약제감수성", 대한수의학회지, 39(1), pp.96~103 (1999)
  32. 김승일, "제주지역 도축돼지의 폐렴병변에서 Mycoplasma hyopneumoniae의 면역조직화학적 발생 분포", 석사, pp.2000
  33. 이석규, "양돈장의 사양 및 위생관리에 따른 출하돈에서의 폐렴발생", 대한수의학회지, 38, pp.751~755 (1998)

관련 논문AI추천

돼지의 마이코플라즈마성 폐렴과 경제형질간의 상관관계 연구김나래, 박병석, 오형길, 유임종, 이종관, 이준헌, 이하복, 전병국한국축산학회 · 한국축산학회지2008 · 제50권 제4호Epidemiological and diagnostic study of porcine Mycoplasma pneumonia in Gangwon province, KoreaChang-Mook Park, Chan-Ho Park, Haeng-Joon Jeong, Ho-Seong Cho, Jae-Wan An, Jeong-Hoon Kim, Ki-Tae Kim, Seung-Man Kim, Yeonsu Oh, Zoya Afzal한국동물위생학회 · 한국동물위생학회지2025 · 제48권 제1호국내 양돈장에서 돼지글래셔병을 동반한 PMWS에 대한 M+ parapac®의 방어효과서태원, 안나경, 윤병일, 정현규, 한정희한국동물위생학회 · 한국동물위생학회지2008 · 제31권 제3호돼지 폐렴병변에서 PCR을 이용한 써코바이러스 2, 돼지생식기호흡기증후군, 마이코플라즈마 폐렴 감염실태 조사강미선, 이정원, 조영숙, 추금숙한국동물위생학회 · 한국동물위생학회지2008 · 제31권 제1호Seroprevalence of selected porcine respiratory pathogens in the pig herds in Chungcheong and Gyeongsang provinces in Korea김명철, 박창식, 전무형, Jia-Qi Chu, Xu-Min Hu한국동물위생학회 · 한국동물위생학회지2009 · 제32권 제1호남원지역 도축돈에 대한 돼지호흡기 복합감염증에 관한 연구강미선, 강민우, 이희선, 정세호한국동물위생학회 · 한국동물위생학회지2013 · 제36권 제2호

이 간행물의 다른 논문 (17건)